Aminopyridine derived compounds as LRRK2 inhibitors
US9393248B1 · kind B1 · utility
0Cited by
0References
18Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Mar 16, 2016 |
| Grant date | Jul 19, 2016 |
| Priority date | — |
| Expiry date | Mar 16, 2036 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D413/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is directed to aminopyridine derived compounds of formula (A)The compounds are considered useful for the treatment of diseases associated with LRRK2 such as a Lewy body dementia, Parkinson's disease or cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.